General Resources / Legal Resources / Medical
Resources / Briefing Papers / State Activity
Hospital Closures / Preventable
Tragedies / Press Room / Search
Our Site / Home
Public Citizen
FOR IMMEDIATE RELEASE November 13, 2003 |
CONTACT: |
Shannon Little, PC, (202) 588-7742 Alicia Aebersold, TAC, (703) 294-6008 LuAnn Canipe, PC (202) 588-7759 |
Serious Mental Illnesses Fall Through Cracks at Federal Research Agency, New Report Finds
National Institute of Mental Health Fails to Adequately Fund Research Into Serious Mental Illnesses, Despite Severe Economic, Societal Costs
WASHINGTON, D.C. The National Institute of Mental
Health (NIMH) continues to underfund scientific research into serious mental illnesses, in
spite of the illnesses enormous economic and societal costs, according to a report
released today by the Treatment Advocacy Center and Public Citizen. NIMH has allocated
funds to research irrelevant to its core mission, leaving serious mental illnesses grossly
underfunded compared to other diseases.
From 1997 to 2002, the period covered by the report, the NIMH budget doubled from $661 million to $1.3 billion. However, the proportion of money spent on research of serious mental illnesses defined as schizophrenia, bipolar disorder, autism, and severe forms of depression, panic disorder and obsessive-compulsive disorder fell by 11 percent, to only 28.5 percent of its budget.
It is estimated that 11.6 million adults in the United States have serious mental illnesses, imposing significant economic and social costs. At any given time, there are approximately 250,000 people homeless or incarcerated who suffer from a serious mental illness. Individuals with a serious mental illness account for 58 percent of total direct costs for all mental illnesses, an amount that includes $40 billion spent under federal programs such as Medicare. However, only 5.8 percent of the NIMH budget funds clinically relevant studies those that are reasonably likely to improve the treatment and quality of life for individuals presently affected.
By not funding research on serious
mental illnesses, NIMH isnt simply hurting scientists, its blocking research
that could improve the lives of millions of the most vulnerable Americans, said E.
Fuller Torrey, M.D., report lead author and president of the Treatment Advocacy Centers
board. NIMHs refusal to do an adequate amount of research on serious mental
illnesses is a federal disgrace and a personal tragedy for individuals affected with these
diseases.
NIMH has rejected many valid research
proposals and funded others that appear to have no relationship to serious mental
illnesses. For example:
� NIMH rejected funding for a trial to improve the treatment of
schizophrenia but funded a study to ascertain how people in Papua New Guinea think
about their own relationships in the real world;
� NIMH rejected funding for a study of bipolar disorder in children
but funded a study of self-esteem in college students.
� NIMH rejected funding for a study to improve the treatment of major
depression but funded a study of sources of friendship in elementary school
students;
� NIMH rejected funding for a study of the causes of postpartum
depression but funded a study of the hearing mechanism of crickets;
� NIMH rejected funding for a study of medication noncompliance in
individuals with serious mental illnesses but funded a study of social communication among
electric fish;
� NIMH rejected funding for research on means of supporting patients
being released from psychiatric hospitals but funded a study of preschool childrens
understanding of love;
� NIMH rejected funding for research on measuring lithium in the brain
but funded a study of how people in Czechoslovakia cope with social change.
In each of the preceding examples, the projects that were rejected would have cost approximately the same amount as those proposed.
Research projects that the Institute
chose to fund may be necessary and valid, the reports authors said, but they should
not come at the expense of NIMHs commitment to studying serious mental illnesses.
Many other federal institutions, ranging from the National Science Foundation (NSF) and
the National Cancer Institute to the U.S. Department of Transportation should be funding
research currently paid for by NIMH.
The enormous increase in
NIMHs budget could have been used to advance research and improve the lives of
millions of people who have serious mental illnesses or whose family and friends do,
said Sidney Wolfe, M.D., report co-author and director of Public Citizens Health
Research Group. NIMHs failure to stick to its knitting is
unacceptable.
Added Mary Zdanowicz, executive
director of the Treatment Advocacy Center, It is nothing less than a national
tragedy to misallocate public research dollars that should be used to offer hope of better
treatment and possibly a cure for severe mental illnesses like schizophrenia and bipolar
disorder.
The reports authors urged
Congress to hold hearings and mandate the percentage of the NIMH budget that is devoted to
research on serious mental illnesses. They also called for better coordination among the
various parts of the National Institutes of Health and the NSF so that research is funded
by the appropriate institutes and NIMH strengthens its focus on serious psychiatric
disorders.
This report is the third in a series of
reports monitoring NIMHs research. To view the report on the Web, go to www.psychlaws.org or
http://www.citizen.org/publications/release.cfm?ID=7292.
###
The Treatment Advocacy Center is a national nonprofit organization working to eliminate barriers to timely treatment of severe mental illnesses. For more information, please visit www.psychlaws.org. Public Citizen is a national nonprofit consumer advocacy organization based in Washington, D.C. For more information, please visit www.citizen.org.
ADDITIONAL INFOGeneral Resources / Legal Resources / Medical Resources / Briefing Papers / State Activity
Hospital Closures / Preventable
Tragedies / Press Room / Search
Our Site / Home
The contents of all material available on the Center's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated. All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made to the Treatment Advocacy Center. Please feel free to call with questions on mental illness, treatment laws or the benefits of medication compliance at 703.294.6001 or send questions via email to [email protected]. Write to us at: The Treatment Advocacy Center; 3300 N. Fairfax Drive; Suite 220; Arlington, VA 22201. Technical comments on the Center's website (www.psychlaws.org) can be sent to [email protected]. The Treatment Advocacy Center is an I.R.C. � 501(c)(3) tax-exempt corporation. Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. � 170. |